Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-25 @ 1:31 AM
NCT ID:
NCT02634294
Eligibility Criteria:
Inclusion Criteria:
1. Age 14-60 years, male or female
2. Allo-HSCT recipients with malignant hematological diseases
3. Disease relapse after allo-HSCT, including hematological relapse, molecular relapse
4. Able to provide written informed consent and to comply with all study procedures
Exclusion Criteria:
1. Pregnant or nursing woman
2. Cardiac ejection factor \< normal lower limit
3. Active acute or chronic GVHD with immunosuppressant treatment
4. Known hypersensitivity or allergy to interferon
5. Patient might develop serious complications according to investigator's experiences
6. Patient is undergoing other experimental medication
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
14 Years
Maximum Age:
60 Years
Study:
NCT02634294
Study Brief:
Protocol Section:
NCT02634294